Status:
COMPLETED
Siewert Type II Esophageal Adenocarcinoma: Relationship Between Histology and Survival
Lead Sponsor:
University of Bologna
Conditions:
Siewert Type II Adenocarcinoma of Esophagogastric Junction
Eligibility:
All Genders
18-85 years
Brief Summary
In Siewert type II adenocarcinoma, the relationship between adenocarcinoma sub types and survival, histologic/biologic patterns related to the presence/absence of gastric greater curvature metastases,...
Detailed Description
In order to achieve further data on the biological patterns of intestinal and diffuse subtypes of esophageal adenocarcinoma (Lauren's classification), on the frequency of gastric greater curvature nod...
Eligibility Criteria
Inclusion
- Siewert type II adenocarcinoma \> 18 year submitted to primary surgery
Exclusion
- Siewert type II adenocarcinoma submitted to neoadjuvant therapy.
- Siewert type I adenocarcinoma. Siewert type III adenocarcinoma Squamous Carcinoma
- \-
Key Trial Info
Start Date :
January 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2017
Estimated Enrollment :
154 Patients enrolled
Trial Details
Trial ID
NCT03416101
Start Date
January 1 2007
End Date
June 30 2017
Last Update
January 30 2018
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Medical and Surgical Sciences University of Bologna
Bologna, Bo, Italy, 40138
2
Sandro Mattioli - Alma Mater Studiorum-University
Bologna, BO, Italy, 40138